These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1674664)

  • 1. Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
    Leake A; Perry EK; Perry RH; Jabeen S; Fairbairn AF; McKeith IG; Ferrier IN
    Biol Psychiatry; 1991 Feb; 29(4):357-64. PubMed ID: 1674664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
    Ince P; Irving D; MacArthur F; Perry RH
    J Neurol Sci; 1991 Dec; 106(2):142-52. PubMed ID: 1802962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
    Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM
    Dementia; 1994; 5(5):215-28. PubMed ID: 7951676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    Cheng AV; Ferrier IN; Morris CM; Jabeen S; Sahgal A; McKeith IG; Edwardson JA; Perry RH; Perry EK
    J Neurol Sci; 1991 Nov; 106(1):50-5. PubMed ID: 1779239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
    Leake A; Perry EK; Perry RH; Fairbairn AF; Ferrier IN
    Biol Psychiatry; 1990 Oct; 28(7):603-8. PubMed ID: 2171685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive dementia with "diffuse Lewy-type inclusions' in cerebral cortex. A case report.
    Ikeda K; Hori A; Bode G
    Arch Psychiatr Nervenkr (1970); 1980; 228(3):243-8. PubMed ID: 6251776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 8. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Lewy body disease: an autopsy case.
    Kuroda S; Otsuki S; Hayashi Y
    Acta Med Okayama; 1987 Jun; 41(3):133-9. PubMed ID: 2820201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
    Fujiyoshi K; Suga H; Okamoto K; Nakamura S; Kameyama M
    J Neurol Neurosurg Psychiatry; 1987 Jul; 50(7):929-32. PubMed ID: 3625218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.
    Terry RD; Hansen LA; DeTeresa R; Davies P; Tobias H; Katzman R
    J Neuropathol Exp Neurol; 1987 May; 46(3):262-8. PubMed ID: 2881985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
    Chan-Palay V; Asan E
    J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia).
    Gibb WR; Esiri MM; Lees AJ
    Brain; 1987 Oct; 110 ( Pt 5)():1131-53. PubMed ID: 2823957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Lewy body disease: clinical features in 15 cases.
    Byrne EJ; Lennox G; Lowe J; Godwin-Austen RB
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):709-17. PubMed ID: 2545827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An electron microscopic study on atypical presenile dementia with numerous Lewy bodies in the cerebral cortex.
    Itoh T; Momma Y; Ogasawara N
    Folia Psychiatr Neurol Jpn; 1982; 36(1):99-106. PubMed ID: 6284602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical Lewy body dementia: clinical features and classification.
    Gibb WR; Luthert PJ; Janota I; Lantos PL
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):185-92. PubMed ID: 2467966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.
    de Vos RA; Jansen EN; Stam FC; Ravid R; Swaab DF
    Clin Neurol Neurosurg; 1995 Feb; 97(1):13-22. PubMed ID: 7788967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
    Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
    JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.